Treatment of Relapsed and/or Chemotherapy Refractory CD33 Positive Acute Myeloid Leukemia by CART-33

NCT01864902 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Relapsed Adult Myeloid Leukemia
Chemotherapy Refractory Adult Myeloid Leukemia

Interventions

BIOLOGICAL: CART33 cells
BIOLOGICAL: anti-CD33 CART
BIOLOGICAL: anti-CD33 CAR T cells

Sponsor

Chinese PLA General Hospital